Literature DB >> 18264802

Integrase, LEDGF/p75 and HIV replication.

E M Poeschla1.   

Abstract

HIV integrates a DNA copy of its genome into a host cell chromosome in each replication cycle. The essential DNA cleaving and joining chemistry of integration is known, but there is less understanding of the process as it occurs in a cell, where two complex and dynamic macromolecular entities are joined: the viral pre-integration complex and chromatin. Among implicated cellular factors, much recent attention has coalesced around LEDGF/p75, a nuclear protein that may act as a chromatin docking factor or receptor for lentiviral pre-integration complexes. LEDGF/p75 tethers HIV integrase to chromatin, protects it from degradation, and strongly influences the genome-wide pattern of HIV integration. Depleting the protein from cells and/or over-expressing its integrase-binding domain blocks viral replication. Current goals are to establish the underlying mechanisms and to determine whether this knowledge can be exploited for antiviral therapy or for targeting lentiviral vector integration in human gene therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18264802      PMCID: PMC3902792          DOI: 10.1007/s00018-008-7540-5

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  203 in total

Review 1.  Intrinsic immunity: a front-line defense against viral attack.

Authors:  Paul D Bieniasz
Journal:  Nat Immunol       Date:  2004-11       Impact factor: 25.606

2.  The avian retroviral IN protein is both necessary and sufficient for integrative recombination in vitro.

Authors:  R A Katz; G Merkel; J Kulkosky; J Leis; A M Skalka
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

3.  Correct integration of retroviral DNA in vitro.

Authors:  P O Brown; B Bowerman; H E Varmus; J M Bishop
Journal:  Cell       Date:  1987-05-08       Impact factor: 41.582

4.  Integration of human immunodeficiency virus type 1 DNA in vitro.

Authors:  C M Farnet; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

5.  A nucleoprotein complex mediates the integration of retroviral DNA.

Authors:  B Bowerman; P O Brown; J M Bishop; H E Varmus
Journal:  Genes Dev       Date:  1989-04       Impact factor: 11.361

6.  The IN protein of Moloney murine leukemia virus processes the viral DNA ends and accomplishes their integration in vitro.

Authors:  R Craigie; T Fujiwara; F Bushman
Journal:  Cell       Date:  1990-08-24       Impact factor: 41.582

Review 7.  Human cell proteins and human immunodeficiency virus DNA integration.

Authors:  Fanny Turlure; Eric Devroe; Pamela A Silver; Alan Engelman
Journal:  Front Biosci       Date:  2004-09-01

8.  Human immunodeficiency virus integration in a cell-free system.

Authors:  V Ellison; H Abrams; T Roe; J Lifson; P Brown
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

9.  Genome-wide analyses of avian sarcoma virus integration sites.

Authors:  Anna Narezkina; Konstantin D Taganov; Samuel Litwin; Radka Stoyanova; Junpei Hayashi; Christoph Seeger; Anna Marie Skalka; Richard A Katz
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

10.  Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences.

Authors:  Rick S Mitchell; Brett F Beitzel; Astrid R W Schroder; Paul Shinn; Huaming Chen; Charles C Berry; Joseph R Ecker; Frederic D Bushman
Journal:  PLoS Biol       Date:  2004-08-17       Impact factor: 8.029

View more
  67 in total

Review 1.  Allosteric inhibitor development targeting HIV-1 integrase.

Authors:  Laith Q Al-Mawsawi; Nouri Neamati
Journal:  ChemMedChem       Date:  2011-01-12       Impact factor: 3.466

2.  Clinical Use of Inhibitors of HIV-1 Integration: Problems and Prospects.

Authors:  S P Korolev; Yu Yu Agapkina; M B Gottikh
Journal:  Acta Naturae       Date:  2011-07       Impact factor: 1.845

3.  Correlation of recombinant integrase activity and functional preintegration complex formation during acute infection by replication-defective integrase mutant human immunodeficiency virus.

Authors:  Xiang Li; Yasuhiro Koh; Alan Engelman
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

4.  Biochemical and biophysical analyses of concerted (U5/U3) integration.

Authors:  Duane P Grandgenett; Sibes Bera; Krishan K Pandey; Ajaykumar C Vora; Jacob Zahm; Sapna Sinha
Journal:  Methods       Date:  2008-11-29       Impact factor: 3.608

5.  Anti-HIV-1 therapeutics: from FDA-approved drugs to hypothetical future targets.

Authors:  Catherine S Adamson; Eric O Freed
Journal:  Mol Interv       Date:  2009-04

6.  Epigenetic repression of LEDGF during UVB exposure by recruitment of SUV39H1 and HDAC1 to the Sp1-responsive elements within LEDGF promoter CpG island.

Authors:  Biju Bhargavan; Bhavana Chhunchha; Nigar Fatma; Eri Kubo; Anil Kumar; Dhirendra P Singh
Journal:  Epigenetics       Date:  2013-02-05       Impact factor: 4.528

7.  Differential effects of human immunodeficiency virus type 1 capsid and cellular factors nucleoporin 153 and LEDGF/p75 on the efficiency and specificity of viral DNA integration.

Authors:  Yasuhiro Koh; Xiaolin Wu; Andrea L Ferris; Kenneth A Matreyek; Steven J Smith; KyeongEun Lee; Vineet N KewalRamani; Stephen H Hughes; Alan Engelman
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

Review 8.  Virological and cellular roles of the transcriptional coactivator LEDGF/p75.

Authors:  Manuel Llano; James Morrison; Eric M Poeschla
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

Review 9.  Chromatin tethering and retroviral integration: recent discoveries and parallels with DNA viruses.

Authors:  Anne M Meehan; Eric M Poeschla
Journal:  Biochim Biophys Acta       Date:  2009-10-15

10.  Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation.

Authors:  Kellie A Jurado; Hao Wang; Alison Slaughter; Lei Feng; Jacques J Kessl; Yasuhiro Koh; Weifeng Wang; Allison Ballandras-Colas; Pratiq A Patel; James R Fuchs; Mamuka Kvaratskhelia; Alan Engelman
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.